Universal Health Services, Inc. (UHS)

NYSE · Health Care · market cap 8.84B

Share price

$180.75

At the last nightly close

Intrinsic value

$267.05

Range $267.05 – $393.00 — the conservative figure is the low end.

Margin of safety

+47.7%

($267.05 − $180.75) ÷ $180.75

EV / EBIT

13.7

On the median operating profit of 15 fiscal years through 2025.

How these numbers are computed

The valuations are calculated in Python from filed accounts, not written by a language model. Three methods run side by side: earnings power value, which capitalises a normalised operating profit; a free-cash-flow model; and the Graham Number as an asset-side cross-check. The conservative figure above is the low end of what they agree on.

The frame gives no credit for growth. A company that compounds will therefore read as expensive against it — that is deliberate. It is a price-discipline floor, not a price target, and it is not a view on what the shares will do.

The EV/EBIT ranking uses the median operating profit of up to fifteen fiscal years — a full cycle — where the free screeners use the last twelve months. When the data cannot support a method, the figure reads n/a rather than a number: a free-cash-flow valuation on a bank, a PEG on erratic earnings, a multiple on a company with no operating profit to speak of.

Fundamentals from SEC EDGAR. Prices, market data and technicals from yfinance. Valuation computed 2026-09-03.

Key metrics

Price / earnings7.4
Price / book1.4
EV / EBITDA5.9
FCF / EV+3.9%
Return on equity+20.9%
Return on assets+8.3%
Debt / equity0.69
Gross margin+44.6%

Market position

52-week high$243.12
52-week low$141.00
From 52-week high-25.7%
RSI (14)63.8
200-day moving average$176.48

Annual financials

PeriodRevenueOperating incomeNet incomeEPSFree cash flow
2025-FY17.36B1.99B1.49B23.42824.5M
2024-FY15.83B1.68B1.14B17.161.12B
2023-FY14.28B1.18B717.8M10.35524.7M
2022-FY13.40B1.00B675.6M9.23262.0M
2021-FY12.64B1.36B991.6M11.8228.0M

Filed figures from SEC EDGAR, in the reporting currency.

Next earnings

Q4 2026 expectedOctober 26, 2026
Consensus EPS estimate5.19

Recent news

The figures above are the arithmetic. To see what a board of eight AI agents makes of them — macro, sector, filings, news and a devil's advocate whose only job is to attack the thesis — run the full analysis on UHS.

Run the board on UHS

10 free analyses · no signup, no card

This page presents computed figures and filed financial data for information only. It is not investment advice, not a recommendation to buy or sell any security, and not a statement about what these shares will do. Sperio is a research tool, not an investment adviser. Figures are derived automatically from public filings and market data and may be incomplete, out of date or wrong. See the Terms & Disclaimer.